Lymphoma
Research conducted at D.O. Persky and co-authors has provided new information about lymphoma
Published in Blood Weekly, February 25th, 2010
According to recent research from the United States, "Of about 20% of patients with relapsed/refractory Hodgkin lymphoma (HL), approximately half achieve long-term remissions after high-dose chemoradiotherapy and autologous stem cell transplantation (HDT/ASCT). Treatment with a comprehensive program using second-line chemotherapy with ICE (ifosfamide, carboplatin, etoposide) before HDT/ASCT identified a clinical prognostic model, but prognostic biologic markers in relapsed/refractory HL remain unclear."
"We sought to determine if we could identify such markers, and if our comprehensive second-line program could overcome their significance. Pre-ICE biopsy specimens of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-02-25)
More Articles from Blood Weekly
- Tufts University, Health Sciences
Researchers develop new tool for gene delivery - University of Maryland Medical Center
Study finds new stent improves ability to keep vessels open for dialysis patients - Wellcome Trust
Patients 'unafraid' to gamble highlight role of amygdala in decision-making - American Heart Association
American Heart Association/American College of Cardiology Scientific Statement: Hospitals Should Be Aware of Rare, Life-Threatening Heart Rhythm - Anemia
Research on anemia discussed by scientists at Boston University - Children's Hospital Boston
Anorexics Found to Have Excess Fat -- In Their Bone Marrow - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
